SUNY Stony Brook NICHD CRS

Site Details

LOCATION

SUNY Stony Brook

Health Science Center at Stony Brook Department of Pediatric Infectious Disease

11th Floor, Rm 031

Stony Brook, NY. 11794-8111

Get Directions

Site Type

CRS

CRS Coordinator

Erin Infanzon

erin.infanzon@stonybrook.edu

CRS Leader

Sharon Nachman, M.D.

sharon.nachman@stonybrook.edu

Site Trials

HIV (and comorbidities)

Open and enrolling

A5359: Long-Acting Antiretroviral Therapy in Non-adherent Persons Living with HIV (PLWH)

This four-step study compares Long-Acting (LA) Injectable Antiretroviral Therapy (ART) to standard of care (SOC) oral ART in previously non-adherent individuals.

· Step 1 is the induction phase and all participants receive SOC oral ART. Participants receive financial incentives for meeting study-specified goals.

· Step 2 is the randomization phase and participants are randomized 1:1 to receive LA injectable ART (cabotegravir and rilpivirine injections) or continue on SOC for 52 weeks.

· Step 3 is the crossover/continuation phase. Participants randomized to LA ART will continue that therapy, and eligible SOC participants will cross-over to receive LA ART for 52 weeks.

· Step 4 is the observational phase that switches participants who received at least one LA ART injection and are no longer eligible for injections back to locally sourced SOC oral ART for 52 weeks.

Mpox

Open and enrolling

A5418:Study of Tecovirimat for Human Monkeypox Virus (STOMP)

A5418 (STOMP) is a study of tecovirimat (also known as TPOXX) for the treatment of human monkeypox virus (HMPXV) disease.